These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. A structural model for the HIV-1 Rev-RRE complex deduced from altered-specificity rev variants isolated by a rapid genetic strategy. Jain C; Belasco JG Cell; 1996 Oct; 87(1):115-25. PubMed ID: 8858154 [TBL] [Abstract][Full Text] [Related]
9. The amino terminal domain of HIV-1 Rev is required for discrimination of the RRE from nonspecific RNA. Daly TJ; Doten RC; Rusche JR; Auer M J Mol Biol; 1995 Oct; 253(2):243-58. PubMed ID: 7563086 [TBL] [Abstract][Full Text] [Related]
10. Molding a peptide into an RNA site by in vivo peptide evolution. Harada K; Martin SS; Tan R; Frankel AD Proc Natl Acad Sci U S A; 1997 Oct; 94(22):11887-92. PubMed ID: 9342332 [TBL] [Abstract][Full Text] [Related]
11. Probing the details of the HIV-1 Rev-Rev-responsive element interaction: effects of modified nucleotides on protein affinity and conformational changes during complex formation. Renwick SB; Critchley AD; Adams CJ; Kelly SM; Price NC; Stockley PG Biochem J; 1995 Jun; 308 ( Pt 2)(Pt 2):447-53. PubMed ID: 7772026 [TBL] [Abstract][Full Text] [Related]
12. Solution structure of the N-terminal zinc fingers of the Xenopus laevis double-stranded RNA-binding protein ZFa. Möller HM; Martinez-Yamout MA; Dyson HJ; Wright PE J Mol Biol; 2005 Aug; 351(4):718-30. PubMed ID: 16051273 [TBL] [Abstract][Full Text] [Related]
13. Peptide-triggered conformational switch in HIV-1 RRE RNA complexes. Gosser Y; Hermann T; Majumdar A; Hu W; Frederick R; Jiang F; Xu W; Patel DJ Nat Struct Biol; 2001 Feb; 8(2):146-50. PubMed ID: 11175904 [TBL] [Abstract][Full Text] [Related]
14. Selection of RNA-binding peptides in vivo. Harada K; Martin SS; Frankel AD Nature; 1996 Mar; 380(6570):175-9. PubMed ID: 8600395 [TBL] [Abstract][Full Text] [Related]
15. Circular dichroism studies of the HIV-1 Rev protein and its specific RNA binding site. Daly TJ; Rusche JR; Maione TE; Frankel AD Biochemistry; 1990 Oct; 29(42):9791-5. PubMed ID: 2125482 [TBL] [Abstract][Full Text] [Related]
16. Exchange of the basic domain of human immunodeficiency virus type 1 Rev for a polyarginine stretch expands the RNA binding specificity, and a minimal arginine cluster is required for optimal RRE RNA binding affinity, nuclear accumulation, and trans-activation. Nam YS; Petrovic A; Jeong KS; Venkatesan S J Virol; 2001 Mar; 75(6):2957-71. PubMed ID: 11222721 [TBL] [Abstract][Full Text] [Related]
17. NMR solution structure of the RNA-binding peptide from human immunodeficiency virus (type 1) Rev. Scanlon MJ; Fairlie DP; Craik DJ; Englebretsen DR; West ML Biochemistry; 1995 Jul; 34(26):8242-9. PubMed ID: 7599117 [TBL] [Abstract][Full Text] [Related]
18. RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element. Luedtke NW; Liu Q; Tor Y Biochemistry; 2003 Oct; 42(39):11391-403. PubMed ID: 14516190 [TBL] [Abstract][Full Text] [Related]
19. Costabilization of peptide and RNA structure in an HIV Rev peptide-RRE complex. Tan R; Frankel AD Biochemistry; 1994 Dec; 33(48):14579-85. PubMed ID: 7981219 [TBL] [Abstract][Full Text] [Related]